Day: March 25, 2021

Þann 25. janúar veitti stjórn Orkuveitu Reykjavíkur heimild til fjármögnunar í formi skuldabréfaútgáfu, víxlaútgáfu eða bankaláns fyrir allt að 15,5 milljarða króna á árinu 2021. Staða Orkuveitunnar er sterk um þessar mundir en sjóðsstaða nemur rúmum 25 milljörðum króna. Auk þess hefur félagið aðgang að samningsbundnum, innlendum lánalínum að fjárhæð 6 milljarða króna fram á næsta ár. Þá á OR eftir að draga á lánasamning við Norræna fjárfestingabankann að fjárhæð 48 milljónir Bandaríkjadala. Gert er ráð fyrir að skuldabréfaútgáfa á innlendum skuldabréfamarkaði verði á bilinu 7-9 milljarðar króna á árinu 2021. Nánari upplýsingar veita: Ingvar Stefánsson,framkvæmdastjóri Fjármála OR, sími: 516-6100, netfang: ingvar.stefansson@or.is  Matei Manolescu, markaðsviðskipti, Fossar markaðir, sími: 522 4008, netfang: matei.manolescu@fossarmarke...

INDIANAPOLIS, March 25, 2021 (GLOBE NEWSWIRE) — Kite Realty Group Trust (NYSE:KRG) is pleased to announce the appointment of Derrick Burks to its Board of Trustees. Mr. Burks is a retired partner from Ernst & Young (EY) where he served for 15 years, including time as managing partner of EY’s Indianapolis office. Kite Realty Group Trust expanded its Board to ten trustees with the addition of Mr. Burks, another independent Board member. “We are thrilled with the addition of Derrick Burks to our Board of Trustees,” said John A. Kite, Chairman and CEO. “Derrick’s wealth of knowledge in a multitude of industries, coupled with his extensive experience with REITs, will greatly strengthen KRG moving forward and further propel us toward our long-term objectives.” Prior to joining Ernst & Young, Mr. Burks spent 24 years with Arthur...

Proceeds to be used to strategically bring forward transformational capital investments in broadband connectivity, including fibre and 5G, enhancing our industry-best customer experience, leading networks and competitive position Accelerated investments to drive significant cash flow benefits from a reduction in capital expenditures commencing in 2023, combined with enhanced revenue and EBITDA growth VANCOUVER, British Columbia, March 25, 2021 (GLOBE NEWSWIRE) — TELUS Corporation (“TELUS”, the “Company” or “we”) (TSX-T, NYSE-TU) announced today that it has entered into an agreement with a syndicate of underwriters led by RBC Capital Markets and CIBC Capital Markets, and together with BMO Capital Markets, Scotiabank and TD Securities Inc. as joint book runners (collectively, the “Underwriters”), pursuant to which the Underwriters...

AUSTIN, Texas, March 25, 2021 (GLOBE NEWSWIRE) — Aspira Women’s Health Inc. (“Aspira”) (Nasdaq: AWH), a bio-analytical based women’s health company focused on gynecologic disease, today reported its financial results for the fourth quarter and year ended December 31, 2020. “In a year dominated by the pandemic, we delivered strong stock price appreciation, growth in revenue and test volume, and financial stability. In addition, we strengthened our team and board of directors. We are starting 2021 by announcing an accelerated product launch of OVASight, a new strategic partnership and increases in our sales footprint,” stated Valerie Palmieri, President and CEO. Recent Corporate Highlights Acceleration of Launch Date of OVASight to Fourth Quarter 2021Aspira announced the acceleration of the target launch date of OVASight to the...

Full Year 2020 Revenue Increases 13% Year-Over-Year to $179.9 Million Company Signs Multiple Contracts in 2020, Including 10-Year, Billion Dollar + Contracts with TSA PreCheck and Centers for Medicare and Medicaid Services Strengthens Balance Sheet with $292.6 Million in IPO Gross Proceeds and Elimination of Debt in the Fourth Quarter Company Issues Full Year and First Quarter 2021 GuidanceASHBURN, Va., March 25, 2021 (GLOBE NEWSWIRE) — Telos® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world’s most security-conscious organizations, today announced financial results for the fourth quarter and fiscal year 2020. “2020 was a momentous year for the Company – we delivered strong revenue growth, continued to expand our customer relationships, and closed our public offering...

Ji’an, Jiangxi, China, March 25, 2021 (GLOBE NEWSWIRE) — Universe Pharmaceuticals INC (the “Company”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today announced the closing of its initial public offering (“Offering”) of 5,000,000 ordinary shares at a public offering price of US$5.00 per ordinary share. The Company received aggregate gross proceeds of US$25 million from this Offering, before deducting underwriting discounts and other related expenses. In addition, the Company has granted the underwriter a 45-day option to purchase up to an additional 750,000 ordinary shares at the public offering price, less underwriting discounts. The ordinary shares began trading on the Nasdaq Global Market on March 23, 2021 under the ticker symbol “UPC”. Proceeds from the Offering will be used for upgrading and expanding...

SAN DIEGO, March 25, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that it has closed its previously announced underwritten public offering of 4,255,000 shares of its common stock, including 555,000 shares sold pursuant to the underwriters’ full exercise of their option to purchase additional shares, at a price to the public of $16.25 per share. The gross proceeds to Exagen from the offering, before deducting the underwriting discounts and commissions and other offering expenses, were approximately $69.1 million. Exagen intends to use the net proceeds from the proposed offering for the development of Multi-omics capabilities, including build out of its clinical laboratory, advancement of its product pipeline, including to support development of tests for fibromyalgia,...